Please assess the completion status of the following clinical trial:

Trial Title: Cardiovascular Function and Ribavirin Pharmacokinetics and Pharmacodynamics in Patients With Lassa Fever

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Positive antigen or PCR test for Lassa fever~* Aged 10 years or above~Exclusion Criteria:~* Patients for end of life care only

- Gender: ALL
- Minimum Age: 10 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Lassa fever (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).